Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



The Stocks the Funds Are Buying

We all know which stocks have made Wall Street's Buy List. What I want to know -- and I'm guessing you do, too -- is who's doing the buying. Which funds are buying Wall Street's most popular stocks ... and how does their judgment compare with that of our Motley Fool CAPS community?

Here's our latest group of contenders:


Last Closing Price

CAPS Rating (Out of 5)






Silverleaf Resorts






IKON Office Solutions



Sources: Motley Fool CAPS, Yahoo! Finance.

Hipster clothier Zumiez has plenty of fund fans. Sadly, only one -- an index fund -- is a high performer by Morningstar's standards.

I'm a fan of index funds. But in this column, I prefer to follow the work of independent stock pickers. Let's take a chance today on Steve Calhoun, manager of the two-star, no-load Fidelity Aggressive Growth (FDEGX) fund.

"Take a chance" really is the appropriate phrasing here. Aggressive Growth is down 14% thus far in 2008, and it trails the category average by seven percentage points year to date.

Why bet on Calhoun, then? He trounced both the S&P 500 and peers last year. And with an alpha rating -- a measurement of the loss or profit derived from stock-picking decisions, rather than market movements -- that veers drastically from the category average, we have reason to believe that his picks would outperform in a recovery.

Finally, and perhaps most importantly, Aggressive Growth's 0.78% expense ratio is well below the toll charged by most domestic stock funds.

Here's a look at the top five stocks Calhoun owns today:


Last closing price

CAPS rating (Out of 5)

St. Jude Medical (NYSE:STJ)



Omniture (NASDAQ:OMTR)






ArthroCare (NASDAQ:ARTC)



Abercrombie & Fitch (NYSE:ANF)



Sources: Morningstar, Motley Fool CAPS.

There are some good choices here. Retailer Abercrombie & Fitch boasts an excellent 0.82 PEG ratio based on current-year earnings projections. And spine surgeon NuVasive, thanks to outstanding top-line growth, remains a well-positioned rocket stock.

My favorite, though, is Omniture, a Motley Fool Stock Advisor selection that resembles Akamai, in that it plays a key role in the upward march of Web commerce. Here's how Fool co-founder David Gardner put it his December 2006 write-up:

Omniture ... is one of the companies leading the business-optimization charge. Its Web analytics do a lot more than count clicks to a given site. By tapping into a company's servers and gathering online data, its software creates a virtual dashboard of customized, real-time performance metrics that alert clients when the needle drops too low or runs too high.

Nice, but the shares have since doubled. Could Omniture still be cheap? CAPS investor spoorts thinks so. Quoting from his January pitch:

The market for Web analytics software and services will reach 1 billion by 2010. Less than 20% of the 10,000 most visited web sites use web analytics. As CEO Josh James states it is like "flying an airplane without the instrument panel". [Omniture] has barely scratched the surface.

I'm inclined to agree. Blistering growth from the likes of Akamai and Google strongly suggests that the Web is expanding as quickly as ever.

But that's my take. What's yours? Would you own Omniture, or any of the stocks in Aggressive Growth's portfolio, at today's prices? Log into CAPS today, and let us know what you think. It's 100% free to participate.

Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 642868, ~/Articles/ArticleHandler.aspx, 10/25/2016 5:13:43 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 7 hours ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:03 PM
ANF $15.52 Down -0.23 -1.46%
Abercrombie and Fi… CAPS Rating: *
ARTC.DL $0.00 Down +0.00 +0.00%
ArthroCare CAPS Rating: No stars
NUVA $67.27 Down -0.15 -0.22%
NuVasive CAPS Rating: *****
SOHU $39.63 Down -2.88 -6.77% CAPS Rating: ***
STJ $79.42 Up +0.06 +0.08%
St. Jude Medical CAPS Rating: **
ZUMZ $22.35 Down -0.15 -0.67%
Zumiez CAPS Rating: **